Journal Mobile Options
Table of Contents
Vol. 86, No. 2, 2008
Issue release date: March 2008
Stereotact Funct Neurosurg 2008;86:87–91
(DOI:10.1159/000112429)

Microelectrode-Guided Deep Brain Stimulation for Tourette Syndrome: Within-Subject Comparison of Different Stimulation Sites

Shields D.C. · Cheng M.L. · Flaherty A.W. · Gale J.T. · Eskandar E.N.
Departments of aNeurosurgery and bNeurology, Massachusetts General Hospital and Harvard Medical School, Boston, Mass., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: As medical therapy for Tourette syndrome (TS) is ineffective in a small subset of patients, surgical interventions, including deep brain stimulation at various sites, have been developed in recent years. Case Description: We present the case of a 40-year-old woman with TS whose severe tics had caused unilateral blindness. Despite trials of more than 40 medications, her symptoms improved significantly only after placement of bilateral deep brain stimulators in the anterior inferior internal capsule. However, symptomatic improvement was not complete, and her electrode connections eventually became permanently damaged by the remaining retrocollic jerks. She underwent removal of the internal capsule electrodes and placement of centromedian nucleus thalamic stimulators with significantly improved tic control. Conclusion: Whereas the anterior internal capsule site had also produced psychiatric side effects such as altered mood and impulse control, the thalamic site has not done so to date. Thus, distinct surgical targets for TS may be appropriate for patients with specific comorbidities.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Jankovic J: Tourette’s syndrome. N Engl J Med 2001;345:1184–1192.
  2. Eapen V, Robertson MM, Zeitlin H, et al: Gilles de la Tourette’s syndrome in special education schools: a United Kingdom Study. J Neurol 1997;244:378–382.
  3. Tanner CM, Goldman SM: Epidemiology of Tourette syndrome. Neurol Clin 1997;15:395–402.
  4. Rauch SL, Baer L, Cosgrove GR, Jenike MA: Neurosurgical treatment of Tourette’s syndrome: a critical review. Compr Psychiatry 1995;36:141–156.
  5. Temel Y, Visser-Vandewalle V: Surgery in Tourette syndrome. Mov Disord 2004;19:3–14.
  6. Hassler R, Dieckmann G: Stereotaxic treatment of tics and inarticulate cries or coprolalia considered as motor obsessional phenomena in Gilles de la Tourette’s disease. Rev Neurol (Paris) 1970;123:89–100.
  7. Graybiel AM, Rauch SL: Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000;28:343–347.
  8. Nuttin BJ, Gabriels LA, Cosyns PR, Meyerson BA, Andreewitch S, Sunaert SG, Maes AF, Dupont PJ, Gybels JM, Gielen F, Demeulemeester HG: Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery 2003;52:1263–1274.
  9. Flaherty AW, Williams ZM, Amirnovin R, Kasper E, Rauch SL, Cosgrove GR, Eskandar EN: Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery 2005;57:E403.
  10. Houeto JL, Karachi C, Mallet L, Pillon B, Yelnik J, Mesnage V, Welter ML, Navarro S, Pelissolo A, Damier P, Pidoux B, Dormont D, Cornu P, Agid Y: Tourette’s syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry 2005;76:992–995.
  11. Visser-Vandewalle V, Temel Y, Boon P, Vreeling F, Colle H, Hoogland G, Groenewegen HJ, van der Linden C: Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome – Report of three cases. J Neurosurg 2003;99:1094–1100.
  12. Tass PA, Klosterkotter J, Schneider F, Lenartz D, Koulousakis A, Sturm V: Obsessive-compulsive disorder: development of demand-controlled deep brain stimulation with methods from stochastic phase resetting. Neuropsychopharmacology 2003;28:S27–S34.
  13. Baraniga M: Remapping of motor cortex. Science 1996;268:1696–1698.
  14. Obeso JA, Rodriguez MC, DeLong MR: Basal ganglia pathophysiology. A critical review. Adv Neurol 1997;74:3–18.
  15. Mink JW: Basal ganglia dysfunction in Tourette’s syndrome: a new hypothesis. Pediatr Neurol 2001;25:190–198.
  16. Graybiel AM, Canales JJ: The neurobiology of repetitive behaviours: clues to the neurobiology of Tourette syndrome. Adv Neurol 2001;85:123–131.
  17. Eidelberg D, Moeller JR, Antonini A, et al: The metabolic anatomy of Tourette’s syndrome. Neurology 1997;48:927–934.
  18. Ziemann U, Paulus W, Rothenberger A: Decreased motor inhibition in Tourette’s disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997;154:1277–1284.
  19. Singer HS, Reiss AL, Brown JE, et al: Volumetric MRI changes in basal ganglia of children with Tourette’s syndrome. Neurology 1993;43:950–956.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50